Capstick N
J Int Med Res. 1977;5 Suppl 5:71-80.
This paper describes the treatment of thirty-three patients who were suffering with obsessional symptoms and who were given the drug clomipramine (Anafranil, Geigy Pharmaceuticals). The symptoms were classified into phobic ruminations, non-phobic ruminations and rituals as well as into the less familiar group of normal and bizarre obsessions. Progress was assessed using the Shapiro card method and a brief description of this method is given. The results show that clomipramine possesses a specific anti-obsessional quality and that the use of this preparation is an effective treatment for obsessional patients. The paper also discusses certain aspects of therapy as well as suggesting an aetiological basis of obsessional symptoms.
本文描述了对33名患有强迫症状的患者的治疗情况，这些患者服用了氯米帕明（安拿芬尼，嘉基制药公司生产）。症状被分为恐惧性沉思、非恐惧性沉思和仪式动作，以及不太常见的正常和怪异强迫观念组。使用夏皮罗卡片法评估进展情况，并对该方法进行了简要描述。结果表明，氯米帕明具有特定的抗强迫特质，使用该制剂对强迫观念患者是一种有效的治疗方法。本文还讨论了治疗的某些方面，并提出了强迫症状的病因学基础。
